Oxford Biotrans secures £2.5m of new investment

6th August 2015

Oxford University Innovation spinout Oxford Biotrans has closed £2.5m in Series A funding.

 

The investment was led by Imperial Innovations with participation from existing shareholders IP Group plc and the University of Oxford and new investors Oxford University Innovations and Technology EIS Fund and De Monchy Aromatics.

 

The company’s first product is natural grade nootkatone, the flavour and scent of grapefruit, which has already created strong market interest and will be available in commercial quantities in the coming months. Oxford Biotrans has already identified several further high-value flavour product targets for its technology and plans to realise further scalable, ‘green’, and economically attractive enzymatic processes for production of these new targets.  Work will also commence to explore targets in other market segments.

 

Read more in the Oxford Biotrans announcement

Press release sign up